acalabrutinib,rituximab,lisaftoclax
astrazeneca,ascentage pharmaceuticals
['acalabrutinib', 'cll', 'lisaftoclax', 'apg-2575', 'ritux']
 no. it is another bcl2i. #ash22 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @EHA_Hematology. Chair, SWG “Aging and Hematology”. @ASH_hematology IMC member